Latest Ketones Stories
Entrenchment of Current Analgesics and Increasing Cost Sensitivity Will Hamper Uptake of Emerging Acute Pain Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Pain Insights, Inc.
DUBLIN, October 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wwkpt5/global_isophorone) has announced the addition of the "Global
Company's new identity to reflect its enhanced focus in chronic diseases of addiction RICHMOND, Va., Oct. 21, 2014 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals Inc.
SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc.
Additional Capital Enable Company to Achieve Additional Milestones in its Business Plan NEW YORK, Oct.
- Orexigen expects to end 2014 with approximately $190 million in cash, cash equivalents and marketable securities SAN DIEGO, Oct. 15, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc.
PAINWeekEnd Irvine presents a full day of pain management CME and takes place on Saturday, October 25 at the Irvine Marriott. Montclair, NJ (PRWEB) October 14,
BOCA RATON, Fla., Oct.
Position Statement Authored by American Academy of Clinical Toxicology, American College of Medical Toxicology and American Association of Poison Control Centers Alexandria,
More Images (1 images) »